Concord Drugs Ltd

Concord Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Concord Drugs Ltd

₹ 72.2 2.21%
02 Apr 9:42 a.m.
concorddrugs.in BSE: 538965
About

Incorporated in 1995, Concord Drugs Ltd manufactures licensed drugs based on
approved formulations

Key Points

Product Portfolio:[1]
a) Pharmaceutical Ready to fill Pellets
b) Multiple Unit Pellet System (MUPS)
c) Tissue Bio Adhesive
d) Injectables (Small Volume Parenterals)
e) Oral Solid Dosages (Tablets & Capsules)
f) Liquid Orals (Syrups & Suspensions)
g) Dry Syrup (Powder)

Website BSE
  • Market Cap ₹ 72.2 Cr.
  • Current Price ₹ 72.2
  • High / Low ₹ 92.5 / 29.0
  • Stock P/E 136
  • Book Value ₹ 34.4
  • Dividend Yield 0.00 %
  • ROCE 4.73 %
  • ROE 0.88 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -6.38% over past five years.
  • Company has a low return on equity of 1.66% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
13.53 11.54 8.79 7.38 12.62 14.47 6.35 11.84 10.77 7.96 13.38 10.07 16.84
12.08 10.80 7.39 5.85 12.06 14.28 5.62 11.05 9.45 7.03 12.44 9.06 15.96
Operating Profit 1.45 0.74 1.40 1.53 0.56 0.19 0.73 0.79 1.32 0.93 0.94 1.01 0.88
OPM % 10.72% 6.41% 15.93% 20.73% 4.44% 1.31% 11.50% 6.67% 12.26% 11.68% 7.03% 10.03% 5.23%
0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.02
Interest 0.45 0.42 0.39 0.39 0.43 0.38 0.37 0.39 0.43 0.53 0.42 0.40 0.30
Depreciation 0.38 0.31 0.38 0.38 0.38 0.39 0.34 0.34 0.37 0.37 0.37 0.34 0.30
Profit before tax 0.62 0.01 0.63 0.77 -0.25 -0.58 0.02 0.07 0.52 0.03 0.15 0.27 0.30
Tax % 25.81% -600.00% 23.81% 31.17% -4.00% -39.66% 50.00% 28.57% 57.69% 33.33% 26.67% 29.63% 26.67%
0.45 0.07 0.49 0.53 -0.24 -0.35 0.01 0.05 0.22 0.01 0.11 0.19 0.22
EPS in Rs 0.51 0.08 0.53 0.57 -0.24 -0.35 0.01 0.05 0.22 0.01 0.11 0.19 0.22
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
33.95 40.02 50.68 57.43 51.80 48.08 51.34 51.33 58.96 51.31 43.26 36.93 48.25
30.72 32.99 42.38 51.93 47.02 44.43 48.00 48.11 53.37 46.97 39.58 33.16 44.49
Operating Profit 3.23 7.03 8.30 5.50 4.78 3.65 3.34 3.22 5.59 4.34 3.68 3.77 3.76
OPM % 9.51% 17.57% 16.38% 9.58% 9.23% 7.59% 6.51% 6.27% 9.48% 8.46% 8.51% 10.21% 7.79%
0.12 0.37 0.15 0.09 0.14 0.09 0.12 3.86 0.10 0.01 0.01 0.01 0.02
Interest 1.78 2.72 2.57 2.36 1.88 1.59 1.54 1.42 1.68 1.62 1.59 1.72 1.65
Depreciation 1.14 3.63 2.91 2.58 2.40 1.71 1.46 1.37 1.76 1.60 1.54 1.42 1.38
Profit before tax 0.43 1.05 2.97 0.65 0.64 0.44 0.46 4.29 2.25 1.13 0.56 0.64 0.75
Tax % 20.93% 33.33% 40.74% 73.85% 50.00% 9.09% 28.26% 23.54% 28.89% 21.24% 25.00% 54.69%
0.34 0.70 1.75 0.16 0.32 0.41 0.33 3.28 1.59 0.89 0.42 0.30 0.53
EPS in Rs 0.47 0.97 2.42 0.22 0.41 0.52 0.38 3.75 1.82 0.96 0.42 0.30 0.53
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -1%
5 Years: -6%
3 Years: -14%
TTM: 11%
Compounded Profit Growth
10 Years: -8%
5 Years: -2%
3 Years: -43%
TTM: 857%
Stock Price CAGR
10 Years: 3%
5 Years: 18%
3 Years: 36%
1 Year: 118%
Return on Equity
10 Years: 3%
5 Years: 2%
3 Years: 2%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 7.24 7.24 7.24 7.24 7.86 7.86 8.74 8.74 8.74 9.32 10.00 10.00 10.00
Reserves 7.33 6.07 7.82 11.75 11.46 15.29 14.74 18.02 19.62 22.38 23.82 24.11 24.42
17.31 21.27 19.99 15.43 13.62 9.83 9.57 12.97 16.43 15.63 14.93 16.91 14.89
12.80 19.63 17.44 21.11 73.48 49.79 24.96 10.15 11.66 9.31 7.55 7.56 12.87
Total Liabilities 44.68 54.21 52.49 55.53 106.42 82.77 58.01 49.88 56.45 56.64 56.30 58.58 62.18
20.84 18.32 15.18 13.64 13.51 11.85 10.52 13.83 13.97 12.86 11.63 12.17 11.48
CWIP 0.00 0.00 0.00 0.00 0.00 0.29 1.00 0.00 0.55 0.92 1.63 2.00 2.05
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.42 1.62 1.62 1.62
23.84 35.89 37.31 41.89 92.91 70.63 46.49 36.05 41.93 41.44 41.42 42.79 47.03
Total Assets 44.68 54.21 52.49 55.53 106.42 82.77 58.01 49.88 56.45 56.64 56.30 58.58 62.18

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2.28 1.75 3.05 1.70 6.88 1.19 2.48 1.62 0.77 2.24 1.96 3.16
-2.14 -1.10 0.23 -1.04 -2.21 -0.34 -0.84 -3.67 -2.44 -2.27 -1.21 -2.32
-0.17 -0.70 -3.42 -3.94 -4.80 -0.73 -1.79 2.07 1.68 0.05 -0.69 -0.87
Net Cash Flow -0.03 -0.06 -0.14 -3.28 -0.13 0.12 -0.15 0.02 0.01 0.03 0.06 -0.02
Free Cash Flow -0.38 0.65 3.28 0.66 4.60 0.85 1.63 -2.05 -1.69 1.38 0.94 0.83
CFO/OP 71% 33% 51% 38% 152% 36% 78% 65% 26% 60% 59% 89%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 180.83 249.90 183.51 99.46 501.49 367.66 180.94 147.41 141.52 116.31 117.87 125.22
Inventory Days 65.28 65.82 76.39 87.31 156.96 171.81 140.84 100.83 151.64 156.25 202.72 252.62
Days Payable 140.64 207.64 92.05 129.50 559.47 393.02 109.72 26.76 62.25 45.98 35.17 45.03
Cash Conversion Cycle 105.47 108.09 167.85 57.27 98.98 146.44 212.05 221.48 230.90 226.58 285.41 332.82
Working Capital Days 55.48 68.04 113.14 4.00 79.27 102.33 103.37 140.30 112.48 145.12 126.56 134.22
ROCE % 7.15% 11.35% 16.06% 8.67% 7.48% 6.16% 6.06% 5.36% 9.30% 5.97% 4.48% 4.73%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Consolidated Revenue from Operations
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Operational Divisions Count
Number
Number of Employees
Count

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
52.13% 52.13% 52.13% 55.41% 55.41% 55.41% 54.39% 54.39% 54.39% 54.39% 54.39% 54.39%
47.87% 47.87% 47.87% 44.59% 44.60% 44.60% 45.61% 45.61% 45.61% 45.61% 45.61% 45.61%
No. of Shareholders 3,2043,1983,9574,0324,7344,7555,0735,0735,2525,1894,7184,597

Documents

Announcements

Annual reports

Credit ratings